 GEMTESA is the second FDA approval for the Sumitovant Biopharma family of companies in the past weekGEMTESA is the first new oral branded OAB medication approved by the U.S. FDA since 2012 and the first product approval for Urovant Sciences GEMTESA is the second FDA approval for the Sumitovant Biopharma family of companies in the past weekGEMTESA is the first new oral branded OAB medication approved by the U.S. FDA since 2012 and the first product approval for Urovant Sciences 